A review of side effects and complications with cannabinoid treatment;Cannabinoide nebenwirkungen und komplikationen

Schmerz

Volumn 17, Issue 4, 2003, Pages 274-279

  Radbruch, L ^a   Nauck, F ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Adverse events; Cannabinoids; Cannabis; Complications; Psychotropic effect

Indexed keywords

AMITRIPTYLINE; CANNABINOID; DEXAMETHASONE; FENTANYL DERIVATIVE; FLUOXETINE; GABAPENTIN; MORPHINE DERIVATIVE; NALOXONE; OXYCODONE; TILIDINE;

BRONCHITIS; COGNITIVE DEFECT; DEPRESSION; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG TOLERANCE; DYSPHORIA; EUPHORIA; HALLUCINATION; HEART MUSCLE ISCHEMIA; HUMAN; HYPOTENSION; LUNG TOXICITY; MOOD DISORDER; PARANOID PSYCHOSIS; PREGNANCY; PSYCHOMOTOR PERFORMANCE; PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SIDE EFFECT; TACHYCARDIA; TREATMENT INDICATION;

AGED; CANNABINOIDS; HUMANS; MALE; MIDDLE AGED; PAIN; PSYCHOTROPIC DRUGS;

EID: 0042510811     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-003-0232-z     Document Type: Review

References (26)

1. Ashton CH (1999) Adverse effects of cannabis and cannabinoids. Br J Anaesth 83: 637-649
2. Bachs L, Morland H (2001) Acute cardiovascular fatalities following cannabis use. Forensic Sci Int 124: 200-203
3. Beal JE, Olson R, Lefkowitz L, Laubenstein L, Bellman P, Yangco B, Morales JO, Murphy R, Powderly W, Plasse TF, Mosdell KW, Shepard KV (1997) Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J Pain Symptom Manage 14: 7-14
4. Bovasso GB (2001) Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 158: 2033-2037
5. Bredt BM, Higuera-Alhino D, Shade SB, Hebert SJ, McCune JM, Abrams DI (2002) Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients. J Clin Pharmacol [Suppl 11] 42: 82S-89S
6. Campbell FA, Tramer MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ (2001) Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 323: 13-16
7. Daisley H, Jones-Le Cointe A, Hutchinson G, Simmons V (1998) Fatal cardiac toxicity temporally related to poly-drug abuse. Vet Hum Toxicol 40: 21-22
8. Degenhardt L, Hall W (2002) Cannabis and psychosis. Curr Psychiatry Rep 4:191-196
9. Gorter RW (1999) Cancer cachexia and cannabinoids. Fortschr Komplementarmed [Suppl 3] 6: 21-22
10. Gupta BD, Jani CB, Shah PH (2001) Fatal'Bhang' poisoning. Med Sci Law 41: 349-352
11. Hall W, Degenhardt L (2000) Cannabis use and psychosis: a review of clinical and epidemio logical evidence. Aust N Z J Psychiatry 34: 26-34
12. Hall W, Solowij N (1998) Adverse effects of cannabis. Lancet 3S2: 1611-1616
13. Hamadeh R, Ardehali A, Locksley RM, York MK (1988) Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient. Chest 94: 432-433
14. Hart CL, Ward AS, Haney M, Comer SD, Foltin RW, Fischman MW (2002) Comparison of smoked marijuana and oral delta (9)-tetrahydrocannabinol in humans. Psychopharmacology (Berl) 164: 407-415
15. Killestein J, Hoogervorst EL, Reif M, Kalkers NF, Van Loenen AC, Staats PG, Gorter RW, Uitdehaag BM, Polman CH (2002) Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology 58: 1404-1407
16. Kosior DA, Filipiak KJ, Stolarz P, Opolski G (2001) Paroxysmal atrial fibrillation following marijuana intoxication: a two-case report of possible association. Int J Cardiol 78: 183-184
17. McLeod AL, McKenna CJ, Northridge DB (2002) Myocardial infarction following the combined recreational use of Viagra and cannabis. Clin Cardiol 25: 133-134
18. Nunez LA, Gurpegui M (2002) Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia. Acta Psychiatr Scand 105: 173-178
19. Sidney S (2002) Cardiovascular consequences of marijuana use. J Clin Pharmacol [Suppl 11] 42: 64S-70S
20. Srivastava MD, Srivastava BI, Brouhard B (1998) Delta 9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology 40: 179-185
21. Staquet M, Gantt C, Machin D (1978) Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain. Clin Pharmacol Ther 23: 397-401
22. Tramer MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ (2001) Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 323: 16-21
23. Van Os J, Bak M, Hanssen M, Bijl RV, Graaf R de, Verdoux H (2002) Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 156: 319-327
24. Ware MA, Doyle CR, Woods R, Lynch ME, Clark AJ (2003) Cannabis use for chronic non-cancer pain: results of a prospective survey. 102: 211-216
25. Williamson EM, Evans FJ (2000) Cannabinoids in clinical practice. Drugs 60: 1303-1314
26. Wright A, Terry P (2002) Modulation of the effects of alcohol on driving-related psychomotor skills by chronic exposure to cannabis. Psychopharmacology (Berl) 160: 213-219